Page last updated: 2024-08-23

dobutamine and Torsade de Pointes

dobutamine has been researched along with Torsade de Pointes in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cuilan, L; Dayi, H; Kangan, C; Peng, G; Quan, F; Richard, CC1
Arakawa, H; Fujikawa, H; Ikeda, U; Kuroki, S; Minezaki, K; Mitsuhashi, T; Nakayama, T; Sato, Y; Sekiguchi, H; Shimada, K1
Finocchi, G; Ometto, R; Vecchia, L; Vincenzi, M1

Other Studies

3 other study(ies) available for dobutamine and Torsade de Pointes

ArticleYear
Dobutamine infusion for unmasking long QT syndrome and torsades de pointes.
    Clinical cardiology, 2009, Volume: 32, Issue:6

    Topics: Adrenergic beta-Agonists; Anti-Arrhythmia Agents; Defibrillators, Implantable; DNA Mutational Analysis; Dobutamine; Electric Countershock; Electrocardiography; Humans; Infusions, Intravenous; KCNQ1 Potassium Channel; Long QT Syndrome; Male; Metoprolol; Middle Aged; Mutation; Recurrence; Syncope; Torsades de Pointes; Treatment Outcome

2009
Induction of torsades de pointes by dobutamine infusion in a patient with idiopathic long QT syndrome.
    Internal medicine (Tokyo, Japan), 1998, Volume: 37, Issue:2

    Topics: Adolescent; Dobutamine; Electrocardiography; Female; Humans; Infusions, Parenteral; Long QT Syndrome; Time Factors; Torsades de Pointes

1998
Torsade de pointes ventricular tachycardia during low dose intermittent dobutamine treatment in a patient with dilated cardiomyopathy and congestive heart failure.
    Pacing and clinical electrophysiology : PACE, 1999, Volume: 22, Issue:2

    Topics: Adrenergic beta-Agonists; Cardiomyopathy, Dilated; Dobutamine; Electrocardiography, Ambulatory; Female; Heart Failure; Humans; Infusions, Intravenous; Middle Aged; Potassium; Torsades de Pointes

1999